Sign in to view content

Episcleral Brachytherapy for Exudative Macular Degeneration

Gregg T. Kokame, MD, MMM, FASRS

Video
Published 2020

Related

Early Fluid-Free Status & Long-Term BCVA Outcomes With Anti-VEGF Treatment in nAMD: Post Hoc Analysis of Pooled Data From HAWK & HARRIER Studies
Chirag D. Jhaveri, MD, FASRS
On Demand Cases, Courses, and Papers
2020
Safety Results of ONS-5010, an Ophthalmic Bevacizumab, in Treated Eyes of Patients With Wet AMD, DME, and BRVO
Suber S. Huang, MD, MBA, FASRS
Annual Meeting Talks
2021
High-dose Aflibercept Therapy in nAMD and DME Eyes With Suboptimal Response to Standard Dose of Anti-VEGF Therapy: A Retrospective Analysis
Jared S. Nielsen, MD, MBA
Annual Meeting Talks
2020

Category: AMD-Neovascular

See more